A Business at a Glance
0 of 1 daily views used (1 remaining). Sign up free for +5 more daily views (6 total), or try AAPL for a full preview.
DNA X, Inc.
SONM
$103K
Mkt Cap
$3.15
+0.66%
DNA X, Inc. (SONM) has a 5-year average return on invested capital (ROIC) of -85.7%. This is below average and may indicate limited pricing power.
DNA X, Inc. (SONM) has a market capitalization of $4M. It is classified as a small-cap stock.
DNA X, Inc. (SONM) does not currently pay a regular dividend.
DNA X, Inc. (SONM) operates in the Telephone & Telegraph Apparatus industry, within the Industrials sector.
DNA X, Inc. (SONM) reported annual revenue of $58 million in its most recent fiscal year, based on SEC EDGAR filings.
DNA X, Inc. (SONM) generated $-9 million in free cash flow in its most recent fiscal year. Negative free cash flow may indicate heavy investment or operational challenges.
DNA X, Inc. (SONM) reported earnings per share (EPS) of $-1091.14 in its most recent fiscal year.
DNA X, Inc. operates in the Telephone & Telegraph Apparatus industry, Industrials sector. Full business description from SEC filing not yet available.
| Metric | TTM | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue | 0 | 58M | 94M | 70M | 55M | 64M |
| Net Income | -21M | - | -90K | -14M | -39M | -30M |
| EPS | $-12.36 | $-1,091.15 | $-1.70 | $-41.65 | $-173.40 | $-1,377.00 |
| Free Cash Flow | 0 | -8.7M | -4.1M | -12M | -39M | -11M |
| ROIC | -1347.2% | - | 3.0% | -72.6% | -163.4% | -109.9% |
| Gross Margin | - | 17.0% | 20.6% | 16.6% | 11.8% | 23.8% |
| Debt/Equity | 0.00 | -0.10 | 0.01 | 0.01 | 0.02 | 0.01 |
| Dividends/Share | $0.00 | - | $0.00 | - | - | - |
| Operating Income | -5.4M | -3.1M | 513K | -14M | -38M | -29M |
| Operating Margin | 0.0% | -5.3% | 0.5% | -20.5% | -69.6% | -45.7% |
| ROE | 0.0% | - | -0.4% | -72.8% | -164.2% | -111.0% |
| Shares Outstanding | 1M | 0M | 0M | 0M | 0M | 0M |
| Metric | ||||||||
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 136M | 116M | 64M | 55M | 70M | 94M | 58M | 0 |
| Gross Margin | 35.4% | 29.7% | 23.8% | 11.8% | 16.6% | 20.6% | 17.0% | N/A |
| R&D | 23M | 26M | 16M | 18M | 8.0M | 1.8M | 14M | 14M |
| SG&A | 7.2M | 15M | 9.8M | 10M | 11M | 8.3M | 3.1M | 5.4M |
| EBIT | 5.4M | -22M | -29M | -38M | -14M | 513K | -3.1M | -5.4M |
| Op. Margin | 4.0% | -19.3% | -45.7% | -69.6% | -20.5% | 0.5% | -5.3% | 0.0% |
| Net Income | -8.9M | -26M | -30M | -39M | -14M | -90K | N/A | -21M |
| Net Margin | -6.5% | -22.2% | -46.8% | -70.8% | -20.2% | -0.1% | N/A | 0.0% |
| Non-Recurring | 0 | 3.8M | 2.2M | 1.5M | -130K | 0 | 7.0M | 7.0M |
| Returns on Capital | ||||||||
| ROIC | 9.0% | -116.8% | -109.9% | -163.4% | -72.6% | 3.0% | N/A | N/M |
| ROE | 20.9% | -168.6% | -111.0% | -164.2% | -72.8% | -0.4% | N/A | 0.0% |
| ROA | -23.6% | -42.1% | -56.6% | -84.5% | -29.7% | -0.2% | N/A | -47.1% |
| Cash Flow | ||||||||
| Op. Cash Flow | 3.9M | -34M | -11M | -38M | -12M | -4.1M | -8.5M | -24M |
| Free Cash Flow | 3.1M | -35M | -11M | -39M | -12M | -4.1M | -8.7M | 0 |
| Owner Earnings | 1.8M | -43M | -14M | -42M | -16M | -7.8M | -14M | -29M |
| CapEx | 787K | 992K | 11K | 46K | 8K | 36K | 214K | 0 |
| Maint. CapEx | 1.9M | 3.5M | 2.7M | 2.1M | 2.4M | 2.2M | 3.6M | 4.3M |
| Growth CapEx | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| D&A | 1.9M | 3.5M | 2.7M | 2.1M | 2.4M | 2.2M | 3.6M | 4.3M |
| CapEx/OCF | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.0% |
| Capital Allocation | ||||||||
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividend Yield | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Buyback Yield | N/A | N/A | N/A | N/A | N/A | 0.0% | N/A | 0.0% |
| Stock-Based Comp | 252K | 6.3M | 1.1M | 1.1M | 1.6M | 1.5M | 1.5M | 1.5M |
| Debt Repayment | 215K | 3.7M | 4.1M | 148K | 67K | 0 | 591K | 591K |
| Balance Sheet | ||||||||
| Net Debt | 461K | -1.1M | -22M | -11M | -13M | -9.2M | -4.8M | 8.3M |
| Cash & Equiv. | 13M | 11M | 22M | 11M | 13M | 9.4M | 5.3M | 1.3M |
| Long-Term Debt | 13M | 362K | 185K | 66K | 67K | 147K | N/A | 5.1M |
| Debt/Equity | 2.63 | 0.40 | 0.01 | 0.02 | 0.01 | 0.01 | -0.10 | 0.00 |
| Interest Coverage | 9.9 | -21.5 | -112.5 | N/A | -147.3 | 34.2 | -106.9 | -106.9 |
| Equity | 5.1M | 26M | 28M | 19M | 20M | 22M | -5.7M | -8.0M |
| Total Assets | 67M | 55M | 50M | 41M | 54M | 56M | 40M | 44M |
| Total Liabilities | 62M | 30M | 22M | 22M | 34M | 34M | 45M | 51M |
| Intangibles | N/A | N/A | N/A | N/A | N/A | 0 | N/A | N/A |
| Retained Earnings | -144M | -166M | -196M | -235M | -250M | -250M | -284M | -304M |
| Working Capital | 16M | 20M | 25M | 15M | 12M | 12M | -12M | -19M |
| Current Assets | 64M | 47M | 46M | 36M | 44M | 44M | 32M | 29M |
| Current Liabilities | 48M | 28M | 20M | 21M | 32M | 32M | 44M | 48M |
| Per Share Data | ||||||||
| EPS | -40.32 | -98.46 | -1,377.00 | -173.40 | -41.65 | -1.70 | -1,091.15 | -12.36 |
| Owner EPS | 7.99 | -165.24 | -661.31 | -187.15 | -48.15 | -146.46 | -416.53 | -23.21 |
| Book Value | 23.30 | 97.28 | 1,306.98 | 83.63 | 59.27 | 422.51 | -174.98 | -6.29 |
| Cash Flow/Share | 17.54 | -127.76 | -485.81 | -172.72 | -36.54 | -76.54 | -260.51 | -12.93 |
| Dividends/Share | N/A | N/A | N/A | N/A | N/A | 0.00 | N/A | 0.00 |
| Shares Out. | 0.2M | 0.3M | 0.0M | 0.2M | 0.3M | 0.1M | 0.0M | 1.3M |
| Valuation | ||||||||
| P/E Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -0.3 |
| P/FCF | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EV/EBIT | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Price/Book | N/A | 9.5 | 4.7 | 0.5 | 0.9 | N/A | N/A | N/A |
| Price/Sales | N/A | 4.3 | 3.9 | 0.9 | 0.4 | N/A | 0.5 | N/A |
| FCF Yield | N/A | -14.2% | -7.9% | -434.2% | -68.6% | N/A | -59.9% | N/A |
| Market Cap | N/A | 243M | 133M | 8.9M | 18M | 0 | 15M | 4.0M |
| Avg. Price | N/A | 13,493.52 | 2,301.67 | 983.31 | 114.75 | 0.00 | 88.53 | 3.15 |
| Year-End Price | N/A | 6,606.00 | 1,245.60 | 168.66 | 79.20 | 0.00 | 55.44 | 3.15 |
DNA X, Inc. passes 1 of 9 quality checks, indicating weak fundamentals.
The company's 5-year average gross margin is 18.0%.
DNA X, Inc. (SONM) has a 5-year average gross margin of 18.0%. This lower margin is typical of capital-intensive or commodity businesses.
The Ledger Terminal provides 7 years of financial data for DNA X, Inc. (SONM), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
DNA X, Inc. (SONM) has a book value per share of $-174.98, based on its most recent annual SEC filing.
No recent press releases.